Your browser doesn't support javascript.
loading
A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
Wadt, K A W; Aoude, L G; Johansson, P; Solinas, A; Pritchard, A; Crainic, O; Andersen, M T; Kiilgaard, J F; Heegaard, S; Sunde, L; Federspiel, B; Madore, J; Thompson, J F; McCarthy, S W; Goodwin, A; Tsao, H; Jönsson, G; Busam, K; Gupta, R; Trent, J M; Gerdes, A-M; Brown, K M; Scolyer, R A; Hayward, N K.
Affiliation
  • Wadt KA; Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
  • Aoude LG; QIMR Berghofer Medical Research Institute, Genetics and Computational Biology, Brisbane, Australia.
  • Johansson P; University of Queensland, Brisbane, Australia.
  • Solinas A; QIMR Berghofer Medical Research Institute, Genetics and Computational Biology, Brisbane, Australia.
  • Pritchard A; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Crainic O; QIMR Berghofer Medical Research Institute, Genetics and Computational Biology, Brisbane, Australia.
  • Andersen MT; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Kiilgaard JF; Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
  • Heegaard S; Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Sunde L; Department of Ophthalmology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Federspiel B; Eye Pathology Institute, Department of Neuroscience and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
  • Madore J; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
  • Thompson JF; Department of Pathology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • McCarthy SW; Melanoma Institute Australia, North Sydney, Australia.
  • Goodwin A; Melanoma Institute Australia, North Sydney, Australia.
  • Tsao H; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Jönsson G; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
  • Busam K; Melanoma Institute Australia, North Sydney, Australia.
  • Gupta R; Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Trent JM; Department of Cancer Genetics, Royal Prince Alfred Hospital, Sydney, Australia.
  • Gerdes AM; Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA.
  • Brown KM; Department of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
  • Scolyer RA; Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
  • Hayward NK; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
Clin Genet ; 88(3): 267-72, 2015 Sep.
Article de En | MEDLINE | ID: mdl-25225168
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome basocellulaire / Mutation germinale / Prédisposition génétique à une maladie / Protéines suppresseurs de tumeurs / Ubiquitin thiolesterase Type d'étude: Prognostic_studies Limites: Female / Humans / Male Langue: En Journal: Clin Genet Année: 2015 Type de document: Article Pays d'affiliation: Danemark Pays de publication: Danemark
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome basocellulaire / Mutation germinale / Prédisposition génétique à une maladie / Protéines suppresseurs de tumeurs / Ubiquitin thiolesterase Type d'étude: Prognostic_studies Limites: Female / Humans / Male Langue: En Journal: Clin Genet Année: 2015 Type de document: Article Pays d'affiliation: Danemark Pays de publication: Danemark